Skip to main content
AIDS 2024

Continuing medical education (CME) credits

Accreditation statement by the European Accreditation Council for Continuing Medical Education 

”The AIDS 2024, the 25th International AIDS Conference, Munich, Germany 22/07/2024 - 22/07/2024, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 21.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.” 

alternative text

Credit conversion 

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.  

Credit will be converted based on one hour of participation equalling one credit for all activities. Physicians and other healthcare professionals will be required to pay a processing fee to the AMA. 

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.  

For other countries, please contact the relevant national or regional accreditation authority. 

How to claim ECMEC®s credits™ 

  • To claim ECMEC®s credits™, please complete this evaluation form after the conference. The deadline to submit the form is Monday, 12 August 2024. No requests will be accepted after this date. 

  • You can view sessions eligible for credits in the online programme by using the filter, “CME accreditation”. Sessions eligible for credits will also be marked on the virtual conference platform.  

  • One hour of participation in an eligible session equals one credit; 30 minutes of participation in an eligible session equals 0.5 credit. 

  • The maximum total number of credits to claim is 21 (5.5 credits each day from 23 to 25 July 2024 and 4.5 credits on 26 July). 

  • Each participant can receive only the number of credits they are entitled to according to their actual participation in the event once they have completed the evaluation form. 

  • Credits may be claimed only for educational sessions in which you participated (in person or virtually) from 23 to 26 July 2024. Participation on any other day is not considered for credit.  
  • Please note that all data from the evaluation form, as well as data on your attendance at the conference, may be shared with the European Accreditation Council for Continuing Medical Education (EACCME®) for the purpose of processing your application for credits. Your data will be stored by IAS – the International AIDS Society – and be accessible to EACCME® for six years. 

  • After you have completed the form, we will verify your attendance and contact you via email to issue the ECMEC®s credits™ certificate. 

Overall learning objectives

After participating in AIDS 2024, participants will be able to:    

  • Inform their practice and interventions with the latest scientific evidence and better integrate it into broader public health and emergency response strategies.  

  • Advance the implementation of available novel prevention and treatment modalities, including long-acting technologies, in different populations and contexts.  

  • Implement person-centred service approaches in their research and practice to promote effective treatment, prevention and care.   

  • Enhance awareness of structural barriers in the HIV response and advocate for evidence-based HIV policies and interventions that address HIV criminalization and other infringements of human rights preventing uptake of services by people living with and affected by HIV.  

pattern above-s

Conflict of interest disclosures

In accordance with the EACCME® guidelines, the IAS ensures that educational sessions at AIDS 2024 provide unbiased, evidence-based content free of commercial influence or bias. All persons in control of programme content are required to disclose any financial relationships they have with companies with commercial interests. 

Disclosure statements of the programme committee members with relevant financial relationships are available here

Disclosure of commercial support for AIDS 2024 is available here

pattern below-s

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.